Patents-Review.com
ClassID:

96519 ⎘

C07J13/007 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)

Recent Application in this class:
#1
20260116912
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #2
20260116911
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #3
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #4
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

 #5
20250257091
2025-08-14

OXYSTEROLS AND METHODS OF USE THEREOF

 #6
20250236638
2025-07-24

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #7
20250206774
2025-06-26

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

 #8
20240409576
2024-12-12

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

 #9
20240368213
2024-11-07

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #10
20240287125
2024-08-29

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #11
20240109934
2024-04-04

ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE

 #12
20240025942
2024-01-25

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #13
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #14
20230348526
2023-11-02

Oxysterols and methods of use thereof

 #15
20230279044
2023-09-07

Neuroactive steroids, compositions, and uses thereof

 #16
20230265121
2023-08-24

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #17
20230192757
2023-06-22

Compositions and methods for treating CNS disorders

 #18
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #19
20230113666
2023-04-13

Compositions and methods for treating CNS disorders

 #20
20220396597
2022-12-15

NMDAR INHIBITING AGENTS AND GABAAR POTENTIATING AGENTS AND USES THEREOF

 #21
20220340614
2022-10-27

CONJUGATED NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE

 #22
20220220150
2022-07-14

Compositions and methods for treating CNS disorders

 #23
20220153776
2022-05-19

ANTAGONISTS OF CB1 RECEPTOR

 #24
20220112203
2022-04-14

Small molecules active against gram-negative bacteria

 #25
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

 #26
20220064207
2022-03-03

Neuroactive steroids and methods of use thereof

 #27
20220048943
2022-02-17

Oxysterols and methods of use thereof

 #28
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #29
20210347812
2021-11-11

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #30
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #31
20210179661
2021-06-17

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #32
20210139531
2021-05-13

19-nor neuroactive steroids and methods of use thereof

 #33
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #34
20210087223
2021-03-25

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #35
20210061848
2021-03-04

Neuroactive steroids, compositions, and uses thereof

 #36
20200392177
2020-12-17

Compositions and methods for treating CNS disorders

 #37
20200317716
2020-10-08

Preparation of bile acids and intermediates thereof

 #38
20200246459
2020-08-06

Compositions and methods for treating CNS disorders

 #39
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #40
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #41
20200095274
2020-03-26

Methods for the purification of deoxycholic acid

 #42
20200048300
2020-02-13

19-NOR neuroactive steroids and methods of use thereof

 #43
20200024302
2020-01-23

Neuroactive steroids, compositions, and uses thereof

 #44
20200024301
2020-01-23

Compositions and methods for treating CNS disorders

 #45
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #46
20190309012
2019-10-10

Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

 #47
20190284227
2019-09-19

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #48
20190211054
2019-07-11

19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #49
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #50
20190135855
2019-05-09

Methods for the purification of deoxycholic acid

 #51
20190135854
2019-05-09

Oxysterols and methods of use thereof

 #52
20190135821
2019-05-09

Small molecules active against gram-negative bacteria

 #53
20190127414
2019-05-02

Neuroactive steroids and methods of use thereof

 #54
20190112331
2019-04-18

19-nor neuroactive steroids and methods of use thereof

 #55
20190077826
2019-03-14

METHODS FOR PREPARING DEOXYCHOLIC ACID

 #56
20190071465
2019-03-07

ANTAGONISTS OF CB1 RECEPTOR

 #57
20190048037
2019-02-14

Preparation of bile acids and intermediates thereof

 #58
20190010184
2019-01-10

Methods for preparation of bile acids and derivatives thereof

 #59
20180340005
2018-11-29

Conjugated Neuroactive Steroid Compositions And Methods Of Use

 #60
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #61
20180237470
2018-08-23

Neuroactive steroids and methods of use thereof

 #62
20180194797
2018-07-12

Oxysterols and methods of use thereof

 #63
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #64
20180111960
2018-04-26

Methods for preparing deoxycholic acid

 #65
20180051052
2018-02-22

19-nor neuroactive steroids and methods of use thereof

 #66
20180037602
2018-02-08

Neuroactive steroids, compositions, and uses thereof

 #67
20170355728
2017-12-14

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #68
20170320905
2017-11-09

Methods for the purification of deoxycholic acid

 #69
20170319695
2017-11-09

Compositions and methods for treating CNS disorders

 #70
20170305960
2017-10-26

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #71
20170283455
2017-10-05

STABLE TOPICAL PHAMACEUTICAL COMPOSITIONS OF HALOBETASOL PROPIONATE

 #72
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #73
20170247405
2017-08-31

Oxysterols and methods of use thereof

 #74
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #75
20170240589
2017-08-24

Compositions and methods for treating CNS disorders

 #76
20170210775
2017-07-27

GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS

 #77
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #78
20170037079
2017-02-09

NEUROACTIVE 13, 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS

 #79
20160297844
2016-10-13

Dehydrogenation catalyst, and carbonyl compound and hydrogen production method using said catalyst

 #80
20160145294
2016-05-26

Antagonists of CB1 receptor

 #81
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #82
20160083417
2016-03-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #83
20150299245
2015-10-22

Preparation of bile acids and intermediates thereof

 #84
20150175650
2015-06-25

SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF

 #85
20150141679
2015-05-21

Methods for the purification of deoxycholic acid

 #86
20140255386
2014-09-11

MICRORNA MODULATORS AND METHOD FOR IDENTIFYING AND USING THE SAME

 #87
20140249120
2014-09-04

Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors

 #88
20140200200
2014-07-17

Antagonists of CB1 receptor

 #89
20120283217
2012-11-08

MODULATORS OF AMYLOID-BETA PRODUCTION

 #90
20110224448
2011-09-15

Preparation of bile acids and intermediates thereof

 #91
20110152552
2011-06-23

Preparation of bile acids and intermediates thereof

 #92
20100179337
2010-07-15

Preparation of bile acids and intermediates thereof

 #93
20100151002
2010-06-17

Guggulphospholipid methods and compositions

 #94
20100145083
2010-06-10

Preparation of bile acids and intermediates thereof

 #95
20100056487
2010-03-04

MODULATORS OF AMYLOID-BETA PRODUCTION

 #96
20090270642
2009-10-29

Preparation of bile acids and intermediates thereof

 #97
20090131389
2009-05-21

Preparation of a crystalline antibiotic substance

 #98
20080009470
2008-01-10

Acremonic Acid Derivatives

 #99
20070055072
2007-03-08

Process for preparing guggulsterones and guggulsterol

 #100
20060211857
2006-09-21

6,7-Oxygenated steroids and uses related thereto